The concept of the Baqsimi is fantastic. Because it is so new some insurances might what a prior authorization but it can be pretty easy.
Baqsimi did a very small study. (I think it was like 14 trained care givers and 13 non-trained family members. Typically small studies aren’t much data to stand on but this was is a little different. One, the difference between the two outcomes what large and two, It is easy to see where that this could easily be the case. It’s one of those things were 14 or 14,000 you would almost certainly see similar numbers.
So, if your provider does have to do a prior authorization, tell them to try this argument.
In a study comparing the nasal glucagon vs. the injectable, 94% of the people trained to administer the nasal glucagon were successful in just under 30 seconds and 93% of the people who had no training at all where able to administer it in 44 seconds. With injectable glucagon, 50% of the people with training were able to administer the injectable glucagon in about 2 1/2 minutes but only 13% administered it correctly. Of the people with no training, nobody was able to do it correctly and only 20% actually got any medication in the person at all. (And it took about 3 minutes). Patients unresponsive due to hypoglycemia, time is of the essence. Glucagon can save the person life and potentially prevent them from falling into a coma. The people around the patient though need to be able to administer the medication. Injectable glucagon is requires mixing power with liquid and, as you can see in the numbers, people have a hard time administering it correctly.